Cynthia Sears, M.D., FIDSA, Bloomberg~Kimmel Professor of Cancer Immunotherapy, was named next Editor-in-Chief of the Journal of Infectious Diseases. Dr. Sears leads the microbiome program… Read More »Dr. Cynthia Sears Named Next Editor-in-Chief of Journal of Infectious Diseases
Liver cancer is one of the fastest-growing causes of cancer death in the U.S. and in many other parts of the world, says Mark Yarchoan,… Read More »Combatting Liver Cancer
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by… Read More »New Advances in Therapies: Five-Drug Combo
In the latest Cancer Matters podcast, Dr Bill Nelson and Dr Jonathan Powell discuss how T cells activated from the immune system are being used… Read More »Cancer Matters with Dr. Bill Nelson – Fighting Cancer with T Cells
Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in… Read More »Great News for Lung Cancer Patients
Some days, when 37-year-old Kristina Baum laces up her running shoes and starts out on her daily training run, she says she feels like someone… Read More »Three-Time Cancer Survivor Ready for New York Marathon
In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Lei Zheng from the Bloomberg~Kimmel Institute for Cancer Immunotherapy about his research into… Read More »Cancer Matters with Dr. Bill Nelson – Immunotherapy and Pancreatic Cancer
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important… Read More »Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event… Read More »Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors
